EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics company, has announced the purchase of 919,331 ordinary shares at a weighted average price of 28 pence per share. The acquired shares will be held in treasury.

The company also confirmed an extension of its additional share buyback programme, initially announced on 21 May 2025. Under this extended programme, EKF plans to conduct further on-market purchases of up to approximately £1.0 million in ordinary shares, pursuant to authorities granted at the company’s last annual general meeting on 20 May 2025.

The move reflects EKF’s ongoing commitment to enhancing shareholder value and maintaining flexibility in its capital management strategy. All shares purchased under the programme will be held in treasury.